Vast molecular profiling and clinical data to become accessible to clinicians and researchers
CAMBRIDGE, MA — February 11, 2015 — Genospace, a precision medicine software company that has developed a comprehensive suite of tools enabling the broad use of genomic and other biomedical data in research and clinical care, today announced that Inova Health System has selected Genospace Population Analytics™ to support a groundbreaking whole-genome sequencing initiative. Inova is a not-for-profit health care system based in the Washington, D.C. metropolitan area that serves more than two million people.
“In recent years, the Inova team has assembled one of the most impressive collections of integrated clinical and genomic data in the world.” said Mick Correll, co-founder and Chief Executive Officer of Genospace. “We are pleased to provide advanced, yet accessible tools that allow Inova physicians, scientists, and other disease experts to conduct advanced analysis and visualization and to explore this remarkable data set.”
The Inova Translational Medicine Institute (ITMI), a division of Inova Health System, is focused on bringing genomic medicine into the community hospital environment. ITMI has sequenced more than 8,000 genomes from individuals representing more than 100 countries. These sequences have been linked to extensive clinical data with the goal of discovering genetic factors contributing to a wide range of diseases. At its current rate of enrollment, ITMI will have sequenced roughly 20,000 genomes with corresponding comprehensive clinical data by the end of 2015. The Genospace platform provides a robust, scalable, and intuitive tool to discover disease associations within these large and complex data sets and enables the translation of these associations into the practice of medicine.
“We selected Genospace for its experience deploying solutions for customers in R&D and clinical care, as well as the analytical capabilities of the platform. Like many providers pushing the envelope of genomic medicine, we needed an effective solution to the challenge of making petabytes of genomic data accessible to the scientists and physicians in our organization. Genospace enables our staff to efficiently gain insight from large quantities of complex information,” said Greg Eley, Chief Technology Officer of the Inova Translational Medicine Institute.
About Inova Health System
Inova is a not-for-profit health care system located in the Washington, D.C. metropolitan area, serving over two million people with over 1,700 licensed beds based in Northern Virginia. Inova consists of five hospitals including the area’s only Level 1 Trauma Center and Level 4 Neonatal Intensive Care unit. Inova encompasses many health services including the nationally and internationally recognized Inova Heart and Vascular Institute (IHVI), Inova Translational Medicine Institute (ITMI) on genomics, Inova Neuroscience Institute and Inova Children’s Hospital. Inova’s mission is to improve the health of the diverse community it serves through excellence in patient care, education and research. More information and statistics about Inova is at www.inova.org.
At Genospace, we are Digital Architects of Genomic Medicine™. Genospace has built a comprehensive platform for precision medicine to enable interpretation, analysis, reporting and collaboration on high-dimensional genomic and other biomedical data. With specific applications supporting research, development, pathology and clinical care, many of the most advanced precision medicine organizations are powered by Genospace. Visit www.genospace.com for more information.